Taken together, PPAR-β/-δ is a critical player in the pathogenesis of the metabolic syndrome, and its ligands may provide useful agents for treating dyslipidemia, obesity, insulin resistance, and atherosclerosis. Here, PPARD is linked to obesity due to melanocortin 4 receptor deficiency.